Two of the world’s most common zero-calorie sweeteners may leave biological traces that extend well beyond their taste receptors, according to new research published in August 2026. A multi-generational study conducted by researchers at Flora C. M. Deo’s laboratory found that both sucralose and stevia produced measurable changes in mice across three successive generations, altering gut bacterial composition, reducing concentrations of beneficial short-chain fatty acids, and changing how metabolism and inflammation-related genes were expressed in intestinal tissue. The findings, published in a peer-reviewed journal and reported by Science Daily, add to a growing body of evidence suggesting that non-nutritive sweeteners are not biologically inert despite their lack of calories.
What happened
The research team exposed mice to doses of sucralose and stevia equivalent to levels that might be consumed by humans using common sweetener products. The exposure continued across three generations, allowing investigators to observe whether any biological changes persisted or compounded over time. Unlike previous studies that examined acute effects over days or weeks, this experimental design tracked physiological changes across generational boundaries.
The study found that both sweeteners altered the composition of gut bacteria in the exposed mice and their offspring. Specific bacterial strains associated with metabolic health declined, while other strains appeared to proliferate in the altered gut environment. Perhaps more significantly, the researchers documented reduced concentrations of short-chain fatty acids, which are produced by certain gut bacteria and serve as a primary energy source for colon cells. These metabolites help maintain the intestinal barrier and play a role in regulating immune responses.
Gene expression analysis revealed changes in intestinal tissue related to metabolic pathways and inflammatory responses. The researchers identified altered expression patterns in genes involved in nutrient processing and immune signaling, suggesting the sweeteners’ effects penetrate beyond bacterial composition to influence host physiology. The team reported that these changes were detectable even in mice born to exposed parents but never directly exposed to the sweeteners themselves, pointing to potential transgenerational mechanisms.
The three-generation design sets this study apart from prior research, which has largely examined acute or short-term effects. If changes persist across generations without continued sweetener exposure, it raises questions about whether early-life or transgenerational effects warrant closer regulatory scrutiny.
Why it matters
The global market for non-nutritive sweeteners has expanded significantly as public health campaigns encourage reduced sugar consumption. Sucralose and stevia are among the most widely used alternatives, appearing in thousands of consumer products from diet sodas to protein bars to tabletop sweetener packets. Understanding whether these substances produce effects beyond their caloric content carries implications for millions of consumers who use them as part of weight management or diabetes control strategies.
Gut microbiome research has expanded rapidly in recent years, with studies linking bacterial composition to immune function, metabolic health, and even neurological outcomes. Short-chain fatty acids, which were reduced in sweetener-exposed mice, serve as a primary energy source for colon cells and help maintain the intestinal barrier. Disruptions to this ecosystem have been associated with conditions including inflammatory bowel disease, type 2 diabetes, and cardiovascular disease, though establishing direct causal relationships in humans remains challenging.
The study highlights gaps in existing regulatory safety assessments. Both the Food and Drug Administration and the European Food Safety Authority have classified sucralose and stevia as safe for consumption based on toxicological evaluations conducted during the approval process. Those assessments focused primarily on traditional endpoints including cancer risk, reproductive toxicity, and organ damage. The current research suggests that microbiome and epigenetic effects, which were not specifically examined in those original evaluations, may merit additional scrutiny.
This does not establish that these sweeteners are unsafe for human consumption. The study was conducted in mice, and significant differences exist between mouse and human physiology that affect how sweeteners are metabolized and how gut microbial communities respond. However, the findings provide a biological mechanism through which even seemingly modest changes in gut composition could produce downstream effects worth monitoring.
Background and context
Sucralose, marketed under the brand name Splenda among others, is an artificial chlorinated disaccharide approved for use in over 100 countries. It was discovered in 1976 and approved for general use in the United States in 1999 after a series of toxicological studies. The compound is approximately 600 times sweeter than sucrose, allowing manufacturers to use much smaller quantities to achieve equivalent sweetness.
Stevia, derived from the leaves of Stevia rebaudiana, is a plant-based sweetener that has gained popularity as a natural alternative to artificial options. Steviol glycosides, the sweet compounds in stevia leaves, have been approved as food additives in numerous jurisdictions. The plant has been used traditionally in South America for centuries, though concentrated extracts used in commercial products differ from traditional preparations.
Previous human studies have produced conflicting results on whether non-nutritive sweeteners meaningfully affect the gut microbiome. Some clinical trials found minor shifts in bacterial composition after several weeks of sweetener consumption, while others detected no significant changes. The new research suggests that even when microbiome alterations appear modest in individual studies, downstream effects on gene expression and metabolite production may be more substantial than currently recognized.
The research team did not respond to requests for comment by publication time.
What to watch next
Scientists not involved in the study have noted that reproducing these findings in human trials would require longer timeframes and larger populations than are typical for initial clinical investigations. Three-generation studies are ethically and practically complex in human populations, meaning that researchers will likely need to rely on additional animal models and improved observational studies before drawing conclusions about human relevance.
Regulatory agencies may face pressure to revisit sweetener safety assessments in light of new evidence on microbiome effects. The European Food Safety Authority and the Food and Drug Administration both maintain ongoing review processes for food additive safety, though it remains uncertain whether the current findings will prompt formal reassessments. Industry groups and public health advocates are likely to interpret the research through different lenses, with potentially competing calls for either stronger regulation or continued acceptance of existing safety classifications.
The research also opens questions about cumulative effects and vulnerable populations. If transgenerational changes are possible, certain groups including pregnant women, children, and individuals with existing gut disorders might warrant additional consideration. Future studies examining dose-response relationships, specific subpopulations, and interactions with dietary patterns could help clarify whether the observed effects in mice translate to human health outcomes.
The study adds to a broader scientific discussion about how food additives interact with human biology in ways not captured by traditional toxicological frameworks. As microbiome research advances, regulators and food manufacturers face increasing questions about what constitutes adequate safety evidence for substances that interact with the trillions of microorganisms inhabiting the human gut.
Conclusion
The research from Flora C. M. Deo’s laboratory represents a significant addition to scientific understanding of non-nutritive sweetener biology, though its implications for human health remain uncertain pending further investigation. The study’s multi-generational design addresses a gap in existing research by examining whether sweetener effects might extend beyond direct exposure, with findings suggesting that both sucralose and stevia produced measurable changes in gut composition, short-chain fatty acid production, and gene expression across mouse generations.
Consumers who use these sweeteners as sugar substitutes will need to weigh the current evidence against their individual health circumstances and dietary goals. For public health authorities and regulators, the study underscores that safety classifications developed decades ago may not fully account for evolving scientific understanding of how food substances interact with complex biological systems. The coming years will likely see increased research attention to these questions, with regulators under growing pressure to determine whether existing frameworks adequately protect consumers from potentially subtle but widespread exposures.
Sources
Science Daily (https://www.sciencedaily.com/releases/2026/08/260830000019.htm)
Source: Science Daily
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: Science Daily — source
